Long-term impact of the adoption of bedaquiline-containing regimens on the burden of drug-resistant tuberculosis in China

BACKGROUND: Currently available injectable agents are inadequate to address the high drug-resistant tuberculosis (DR-TB) burden in China. Regimens including the oral agent bedaquiline have been shown to be efficacious and safe, leading to its incorporation into multiple national TB treatment program...

Descripción completa

Detalles Bibliográficos
Autores principales: Agnarson, Abela Mpobela, Wang, Xiao Chun, Potluri, Ravi, Bhandari, Hitesh, Dhir, Amit, Kambili, Chrispin, Metz, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011376/
https://www.ncbi.nlm.nih.gov/pubmed/32041542
http://dx.doi.org/10.1186/s12879-020-4795-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011376/
https://www.ncbi.nlm.nih.gov/pubmed/32041542
http://dx.doi.org/10.1186/s12879-020-4795-4

Ejemplares similares